Search PDMR transactions

Notifier
Name of person with notification obligation
PharmaExec Consulting AB
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Per Thomas Lönngren
Position
Chairman of the Board of Directors
Initial notification
No
Amendment
Yes
Details of amendment
Ändrat till mitt förtag då jag av misstag satte mig själv som anmälnings skyldig
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 129 Quantity 5.93 SEK 23/11/2021 NORDEA - SYSTEMATIC INTERNALISER
Share Egetis Therapeutics AB SE0003815604 Acquisition 65,000 Quantity 6.10 SEK 24/11/2021 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 23/11/2021 NORDEA - SYSTEMATIC INTERNALISER 129 (Quantity) 5.93 SEK
Egetis Therapeutics AB SE0003815604 Acquisition 24/11/2021 Outside a trading venue 65,000 (Quantity) 6.10 SEK
<< Back